Medicare Enrolled

Dr. Wagdy Kades, M.D.

Rheumatology · Los Angeles, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1245 WILSHIRE BLVD STE 775, Los Angeles, CA 90017
2134845397
In practice since 2006 (19 years)
NPI: 1326080060 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kades from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kades? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kades

Dr. Wagdy Kades is a rheumatology specialist in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kades performed 1,533 Medicare services across 697 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kades received a total of $41,426 from 50 pharmaceutical and/or device companies across 1376 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kades is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 40% volume in CA $41,426 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,533
Medicare services
Top 40% in CA for rheumatology
697
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~81 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
678 $104 $252
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
244 $88 $200
Viscosupplementation injection for joint
An injection of hyaluronic acid or a derivative into a joint to provide lubrication and cushioning.
185 $57 $150
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
139 $20 $48
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
73 $56 $270
Injection, methylprednisolone acetate, 40 mg 60 $6 $10
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
55 $77 $178
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
47 $139 $327
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
21 $135 $352
Complete ultrasound scan of joint
An ultrasound exam that uses sound waves to create detailed images of a joint. This procedure allows for the visualization of the joint's internal structures.
19 $38 $105
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
12 $51 $112
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.8% high complexity
33.1% medium
62.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$41,426
Total received (2018-2024)
Avg $5,918/year across 7 years
Top 12% in CA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
1,376
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,886 (62.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,256 (19.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$7,284 (17.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$11,521
2023
$4,979
2022
$4,350
2021
$7,462
2020
$2,284
2019
$7,059
2018
$3,771

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$7,461
Amgen Inc.
$875
ABBVIE INC.
$439
Janssen Biotech, Inc.
$365
ANI Pharmaceuticals, Inc.
$341
UCB, Inc.
$330
Novartis Pharmaceuticals Corporation
$290
Boehringer Ingelheim Pharmaceuticals, Inc.
$192
Alexion Pharmaceuticals, Inc.
$182
Mallinckrodt Hospital Products Inc.
$176
PFIZER INC.
$145
Fresenius Kabi USA, LLC
$121
Radius Health, Inc.
$115
Lilly USA, LLC
$103
AstraZeneca Pharmaceuticals LP
$85
GENZYME CORPORATION
$74
Aurinia Pharma U.S., Inc.
$71
SCILEX PHARMACEUTICALS INC.
$40
SOBI, INC
$32
Fidia Pharma USA Inc.
$31
Abbott Laboratories
$28
Octapharma USA, Inc.
$24
Top 3 companies account for 76.2% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$9,335
Horizon Therapeutics plc
$7,959
Amgen Inc.
$4,039
Janssen Biotech, Inc.
$2,339
PFIZER INC.
$1,894
ABBVIE INC.
$1,714
Novartis Pharmaceuticals Corporation
$1,266
UCB, Inc.
$1,251
Mallinckrodt Hospital Products Inc.
$1,027
Lilly USA, LLC
$956
AbbVie, Inc.
$879
GENZYME CORPORATION
$840
Alexion Pharmaceuticals, Inc.
$792
E.R. Squibb & Sons, L.L.C.
$779
AbbVie Inc.
$724
Radius Health, Inc.
$641
AstraZeneca Pharmaceuticals LP
$622
Boehringer Ingelheim Pharmaceuticals, Inc.
$540
ANI Pharmaceuticals, Inc.
$520
Horizon Pharma plc
$385
Aurinia Pharma U.S., Inc.
$306
Fresenius Kabi USA, LLC
$287
Genentech USA, Inc.
$251
Mallinckrodt LLC
$200
Hikma Pharmaceuticals USA
$189
Celgene Corporation
$182
Mallinckrodt Enterprises LLC
$176
MEDAC PHARMA, INC.
$157
MEDEXUS PHARMA, INC.
$157
Antares Pharma, Inc.
$147
Sobi, Inc
$111
Organon LLC
$92
ASCEND Therapeutics US, LLC
$80
West-Ward Pharmaceuticals
$68
Ironwood Pharmaceuticals, Inc
$61
ASCEND THERAPEUTICS US, LLC
$58
Sebela Pharmaceuticals Inc.
$46
SOBI, INC
$45
Flexion Therapeutics, Inc.
$42
SCILEX PHARMACEUTICALS INC.
$40
Fidia Pharma USA Inc.
$31
Abbott Laboratories
$28
Actelion Pharmaceuticals US, Inc.
$27
SANOFI-AVENTIS U.S. LLC
$25
Takeda Pharmaceuticals U.S.A., Inc.
$24
Octapharma USA, Inc.
$24
Gilead Sciences, Inc.
$22
DePuy Synthes Sales Inc.
$19
Merck Sharp & Dohme Corporation
$15
Avion Pharmaceuticals
$14
Top 3 companies account for 51.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · BENLYSTA · BINOSTO · Balcoltra · Bimzelx · COLOGUARD · COSENTYX · CYLTEZO · Cimzia · DUEXIS · DUZALLO · ETERNA · EVENITY · EVUSHELD · Enbrel · FORTEO · HADLIMA · HUMIRA · HYMOVIS · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · MOVANTIK · Mitigare · Neupro · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENCIA · ORTHOVISC · OTREXUP · Otezla · Otrexup · PAXLOVID · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RIDAURA · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · Strensiq · TALTZ · TAVNEOS · TREMFYA · Tymlos · Uloric · XELJANZ · XYOSTED · ZTLido · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (62%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Los Angeles?
Compare rheumatologists in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
213
Per 100K population
2.2
County median income
$87,760
Nearest hospital
PIH HEALTH GOOD SAMARITAN HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kades is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 12% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kades experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kades performed 678 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kades receive payments from pharmaceutical companies?
Yes. Dr. Kades received a total of $41,426 from 50 companies across 1,376 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kades's costs compare to other rheumatologists in Los Angeles?
Dr. Kades's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kades) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →